Astra Aktiebolaget v G D Searle & Co

Link copied
Case Copied 50 min read

Trade marks act 1955

decision of a delegate of the registrar OF TRADE MARKS WITH REASONS

Opposition by G D SEARLE & CO to Trade Mark Application No. 582300 in the Name of ASTRA AKTIEBOLAG

As provided in the transitional provisions of Part 22 of the Trade Marks Act 1995 the provisions of the Trade Marks Act 1955 continue to govern this opposition.  Accordingly, unless otherwise specified, any reference to the Act in this decision is a reference to the Trade Marks Act 1955.

The application

On 29 June 1992 Astra Aktiebolaget (Astra), a Swedish corporation, lodged an application, numbered 581300, seeking registration of the trade mark NITROMIST in respect of “All goods in class 5; pharmaceutical preparations and substances”.  This specification was subsequently amended following an objection by an examiner of trade marks to “pharmaceutical preparations for the treatment of cardio vascular diseases” and it was in respect of that specification that the application was advertised as accepted in the Official Journal of 23 September 1993.  Following the hearing of the opposition Astra requested that the statement of goods be amended to “pharmaceutical preparations for the treatment of cardiovascular diseases supplied by prescription”.

The opposition

Notice of opposition to the registration of the trade mark was lodged in accordance with s49 of the Act by G D Searle & Co (Searle) on 22 March 1994.  The grounds of opposition were comprehensive and raised issues concerning proprietorship of the applicant’s mark, the distinctiveness of the mark, the use or intention to use the mark, the deceptiveness of the  mark under both s28 and s33 of the Act.  It also invoked the Registrar’s discretion to refuse registration of the mark.

The evidence

The evidence stages of the proceedings were completed on 19 August 1996.  The evidence consists of:

Evidence in support:

  • statutory declaration of Kevin Patrick Hendry made 5 April 1995 together with           Exhibits 1-11

  • a second statutory declaration of Kevin Patrick Hendry made 22 May 1995 together    with Exhibit 12

Evidence in answer:

  • statutory declaration of Robert N Salt made 15 April 1996 with Exhibits A-C

Evidence in reply:

  • statutory declaration of Dr Robert Hedley Mannell made 18 July 1996 with Annexure A

  • statutory declaration of John Boyd made 16 August 1996 with Exhibits 13-15

On 4 December 1996 Astra requested a hearing of the matter.  A hearing was set down for 7 March 1997 in Canberra at which Mr Malcolm Royal of Phillips Ormonde & Fitzpatrick, patent attorneys, appeared on behalf of Astra and Mr Simon Williams of Spruson & Ferguson, patent attorneys, appeared for Searle.

Submissions

Mr Williams began his submissions by stating that without abandoning any of the grounds set out in the notice of opposition he intended to rely primarily upon the grounds relating to the deceptiveness of Astra’s trade mark in terms of ss28 and 33 of the Act.

In respect of s28 Mr Williams submitted that regard must be had to the actual market awareness of the opponent’s trade mark NITRADISC as used while…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Astra Aktiebolaget v G D Searle & Co and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1997] ATMO 15
Decision Date

CaseChat Overview and Summary

Astra Aktiebolaget, the applicant, sought to register a trade mark for "Cardiac stimulant" in relation to pharmaceutical preparations for the treatment of cardiovascular diseases. G D Searle & Co, the opponent, opposed the registration. The matter came before the Registrar of Trade Marks, and subsequently, the applicant appealed to the Federal Court of Australia.

The primary legal issue before the Federal Court was whether the proposed trade mark "Cardiac stimulant" was inherently deceptive or misleading, and therefore disentitled to registration under section 26(a) of the Trade Marks Act 1955 (Cth). The court was required to consider whether the mark, when applied to the goods, would convey a false impression as to the nature, quality, or characteristics of those goods.

The court reasoned that the term "cardiac stimulant" is a descriptive term for a class of pharmaceutical preparations that stimulate the heart. It is not a coined or invented word, nor is it a word that has acquired a secondary meaning indicating a specific product of the applicant. Therefore, the court held that the mark was inherently deceptive because it would be understood by the public as a description of the goods themselves, rather than as a trade mark distinguishing the applicant's goods from those of other traders. The court applied the principle that a word which is merely descriptive of the goods cannot be registered as a trade mark.

The appeal was dismissed, and the applicant's application for registration of the trade mark "Cardiac stimulant" was refused.

Background

Background to the litigation

Astra Aktiebolaget, a Swedish corporation, filed an application on 29 June 1992 to register the trade mark NITROMIST for "pharmaceutical preparations for the treatment of cardiovascular diseases". G D Searle & Co opposed the registration, arguing that Astra's mark was deceptively similar to Searle's registered marks NITRADISC and NITRODISC, which were used for nitroglycerin preparations for the treatment of heart disease. The opposition raised issues concerning the distinctiveness, use, and deceptiveness of Astra's mark, as well as the Registrar's discretion to refuse registration. The evidence stages of the proceedings were completed on 19 August 1996, with submissions from both parties focusing on the deceptiveness of Astra's mark in terms of sections 28 and 33 of the Trade Marks Act 1955. The hearing was set down for 7 March 1997 in Canberra, where arguments were presented by representatives of both parties. The decision maker found that Searle had failed to make a case under sections 28 and 33 of the Act, and the opposition was dismissed. The trade mark NITROMIST was directed to be registered, subject to the opponent's right of appeal, and costs were awarded to the applicant.

This case involves an opposition to the registration of the trade mark NITROMIST by Astra Aktiebolaget, a Swedish corporation, filed by G D Searle & Co (Searle). The application for registration of the trade mark NITROMIST was initially filed on 29 June 1992 and subsequently amended to cover "pharmaceutical preparations for the treatment of cardiovascular diseases supplied by prescription". Searle lodged a notice of opposition on 22 March 1994, raising comprehensive grounds relating to proprietorship, distinctiveness, use or intention to use, deceptiveness under sections 28 and 33 of the Trade Marks Act 1955, and the Registrar’s discretion to refuse registration. The evidence stages of the proceedings concluded on 19 August 1996, with submissions made by both parties on 7 March 1997 in Canberra. The submissions focused primarily on the deceptiveness of Astra’s trade mark in terms of sections 28 and 33 of the Act, considering factors such as aural and visual similarity, market awareness, and the nature of the goods. The decision, rendered by Michael Homann, found that Searle had failed to establish a case under sections 28 and 33, leading to the dismissal of the opposition and the direction that the trade mark should be registered, subject to the opponent’s right of appeal. Costs were awarded to the applicant.

Decision

Reasons for decision

Issues
1. Whether the evidence of Dr. Robert Hedley Mannell should be admitted as evidence in reply.
2. Whether the search of the Trade Marks Office database provided by Kevin Patrick Hendry is complete and accurate.
3. Whether the marks NITRADISC and NITROMIST are substantially identical.
4. Whether the marks NITRADISC and NITROMIST are deceptively similar.
5. Whether there is a reasonable likelihood of deception or confusion among a substantial number of persons if the applicant's mark NITROMIST is used in a normal or fair manner.
6. Whether there is a need to find blameworthy conduct in opposition proceedings based on s28(a) of the Trade Marks Act 1955.

Held
1. Whether the evidence of Dr. Robert Hedley Mannell should be admitted as evidence in reply.
- The court concluded that the Mannell declaration is directly in reply to the evidence in answer and therefore admissible.
- Result: Evidence admitted.

2. Whether the search of the Trade Marks Office database provided by Kevin Patrick Hendry is complete and accurate.
- The court concluded that while there were discrepancies in the database search, the evidence was sufficient to determine the state of the Register.
- Result: Evidence deemed sufficient.

3. Whether the marks NITRADISC and NITROMIST are substantially identical.
- The court concluded that the marks are not substantially identical due to obvious differences in the words "DISC" and "MIST."
- Result: Marks found not substantially identical.

4. Whether the marks NITRADISC and NITROMIST are deceptively similar.
- The court concluded that the marks are not deceptively similar, considering their distinct sounds and the specialized nature of the goods.
- Result: Marks found not deceptively similar.

5. Whether there is a reasonable likelihood of deception or confusion among a substantial number of persons if the applicant's mark NITROMIST is used in a normal or fair manner.
- The court concluded that there is no reasonable likelihood of deception or confusion among a substantial number of persons.
- Result: No reasonable likelihood of deception or confusion found.

6. Whether there is a need to find blameworthy conduct in opposition proceedings based on s28(a) of the Trade Marks Act 1955.
- The court concluded that there was no need to find blameworthy conduct in opposition proceedings based on s28(a).
- Result: No blameworthy conduct required.

Ratio Decidendi

Legal Principle Established

The case of Astra Aktiebolaget v G D Searle & Co revolves around the opposition to the registration of the trade mark NITROMIST by Astra Aktiebolaget (Astra) and the opposition by G D Searle & Co (Searle). The opposition was based on several grounds, primarily focusing on the deceptiveness of Astra's trade mark under sections 28 and 33 of the Trade Marks Act 1955. The hearing officer, Michael Homann, meticulously examined each issue presented in the opposition, providing detailed reasoning and applying established legal principles to reach a conclusion.

Firstly, the hearing officer addressed the admissibility of Dr. Robert Hedley Mannell's evidence in reply. Searle's counsel argued that the evidence should be disregarded as it was not in reply to any evidence in answer, and Astra had not had the opportunity to respond to it. The hearing officer found that the evidence was indeed in reply to Astra's evidence in answer, specifically responding to the opinion of Robert N Salt that the two marks would not cause confusion. The hearing officer ruled that the evidence was admissible as it directly countered the opinion evidence presented by Astra. This decision aligns with the principle that opinion evidence regarding the likelihood of deception or confusion is not admissible, as it is the tribunal's role to make such determinations.

Secondly, the accuracy and completeness of the search of the Trade Marks Office database provided by Kevin Patrick Hendry were scrutinized. Searle argued that the search was incomplete and selective, while Astra contended that it was sufficient. The hearing officer concluded that the search, while not exhaustive, was sufficient for the purposes of the opposition, as it highlighted the relevant marks and the differences between them.

The hearing officer then examined whether the marks NITRADISC and NITROMIST were substantially identical. The comparison between the marks revealed significant differences, particularly in the suffixes "DISC" and "MIST," which have different meanings and pronunciations. The hearing officer found that the marks were not substantially identical under section 33 of the Act.

Regarding deceptive similarity under section 33, the hearing officer considered the look, sound, and context of the marks. Despite the common prefix "NITRO-," the hearing officer determined that the suffixes and overall sound of the marks were distinct enough to prevent aural confusion. The hearing officer also noted the specialized nature of the market, where professionals would be less likely to confuse the marks.

Under section 28, the hearing officer assessed whether there was a reasonable likelihood of deception or confusion among a substantial number of persons. The established reputation of Searle's mark NITRADISC was considered, but the hearing officer concluded that the marks were not likely to cause confusion due to their distinct differences and the specialized market context.

The hearing officer further addressed the need for blameworthy conduct in opposition proceedings based on section 28(a) of the Act. The hearing officer found that there was no requirement to demonstrate blameworthy conduct in opposition proceedings, as the case law did not mandate such conduct for a successful opposition under section 28(a).

Ultimately, the hearing officer dismissed the opposition, finding that Searle had not established a case under sections 28 and 33 of the Act. The trade mark NITROMIST was directed to be registered, subject to Searle's right of appeal, and costs were awarded to Astra.

The ratio decidendi of this case is that the opposition to the registration of the trade mark NITROMIST by Searle failed on the grounds that the marks NITRADISC and NITROMIST were neither substantially identical nor deceptively similar, and there was no requirement to demonstrate blameworthy conduct in opposition proceedings under section 28(a) of the Trade Marks Act 1955. The hearing officer's decision underscores the importance of detailed market analysis, specialized context, and established legal principles in determining the deceptiveness of trade marks.